North America Closed System Transfer Devices Market Size, Share & Trends Analysis Report By Type (Membrane-to-Membrane, and Needleless), By Component, By Technology, By Closing Mechanism, By End User, By Country and Growth Forecast, 2024 - 2031

The North America Closed System Transfer Devices Market would witness market growth of 13.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Closed System Transfer Devices Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $765 million by 2031. The Canada market is experiencing a CAGR of 15.7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 15.1% during (2024 - 2031).



The closed system transfer devices refer to the healthcare industry segment that involves manufacturing, distributing, and selling devices designed to handle and transfer hazardous drugs safely. These devices provide a closed system for transferring medications from vials, ampules, or bags to syringes, infusion containers, or patient administration sets, thereby minimizing the risk of exposure to hazardous drugs for healthcare workers, patients, and the environment.

The adoption of closed system transfer devices (CSTDs) has been driven by several factors, reflecting a growing recognition of the importance of safety measures in healthcare settings. For example, healthcare workers face significant risks of exposure to hazardous drugs, including chemotherapy agents, antivirals, and hormones. Increased awareness of these occupational hazards has prompted healthcare facilities to prioritize safety measures such as CSTDs to protect their staff and patients.

With increasing cancer rates in Mexico, there is a corresponding rise in the demand for chemotherapy as a primary treatment modality. Chemotherapy drugs are potent and hazardous substances that require careful handling to minimize the risk. Cancer is Mexico’s third most common cause of death, according to All.Can. 2020 saw the registration of more than 195,000 new cases.

The highest prevalence was found for cervical cancer (9,439), thyroid (11,227), colon (11,191), prostate (26.742), and breast cancer (29.929). There were 90,222 incidents of deaths in the nation in that same year. As the demand for chemotherapy increases, so does the need for safety measures like CSTDs to ensure safe drug preparation and administration. Hence, the high healthcare expenditure and cancer prevalence propel the market’s growth.

Based on Type, the market is segmented into Membrane-to-Membrane, and Needleless. Based on Component, the market is segmented into Vial access components, Female Components, Male Luers, Bag Spikes, and Others. Based on Technology, the market is segmented into Diaphragm-based devices, Compartmentalized devices, and Air cleaning/filtration devices. Based on Closing Mechanism, the market is segmented into Luer Lock System, Push-to-Turn System, Click-to-Lock System, and Color-to-Color alignment System. Based on End User, the market is segmented into Hospitals & Clinics, Oncology Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Becton, Dickinson and Company
• ICU Medical, Inc.
• B.Braun Melsungen AG
• Baxter International, Inc
• Terumo Corporation
• Equashield LLC
• Simplivia Healthcare Ltd.
• CODAN Medizinische Geräte GmbH
• Corning Incorporated
• Vygon SAS

Market Report Segmentation

By Type

• Membrane-to-Membrane
• Needleless

By Component

• Vial access components
• Female Components
• Male Luers
• Bag Spikes
• Others

By Technology

• Diaphragm-based devices
• Compartmentalized devices
• Air cleaning/filtration devices

By Closing Mechanism

• Luer Lock System
• Push-to-Turn System
• Click-to-Lock System
• Color-to-Color alignment System

By End User

• Hospitals & Clinics
• Oncology Centers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America